Why would a person have an empty sella turcica?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Empty Sella Turcica: Causes and Clinical Significance

Empty sella turcica occurs when cerebrospinal fluid fills the sella turcica through a defect in the sellar diaphragm, compressing the pituitary gland against the sellar floor and walls. This can arise from multiple mechanisms, both primary (idiopathic) and secondary (acquired) causes 1.

Primary Mechanisms

Anatomical Defect with CSF Herniation

The most common mechanism involves herniation of the subarachnoid space through an incompetent or deficient sellar diaphragm, allowing CSF to enter and fill the sella 2, 3. This can occur with or without elevated intracranial pressure.

Increased Intracranial Pressure

Chronically elevated intracranial pressure is a significant contributor, particularly in younger, obese patients. The classic demographic is obese, hypertensive, multiparous women 2, 4. Idiopathic intracranial hypertension (IIH) is strongly associated with empty sella—93% of IIH patients show orbital findings suggestive of elevated pressure compared to only 14% with incidental empty sella 4.

Spontaneous Pituitary Adenoma Necrosis

An important but underrecognized cause is spontaneous necrosis of a previous pituitary adenoma 5. This theory explains why many patients with empty sella have pituitary insufficiency, hypersecretion, or visual field defects—these represent residual manifestations of the original adenoma 5. The empty sella essentially represents a late stage in the natural history of some pituitary tumors.

Secondary Causes

Secondary empty sella results from identifiable pituitary injury:

  • Pituitary apoplexy (hemorrhage or infarction)
  • Surgical resection of pituitary tumors
  • Radiation therapy to the sellar region
  • Traumatic brain injury (significant predictor with P = 0.003) 1
  • Previous pituitary gland hypertrophy (e.g., pregnancy-related) with subsequent involution 5

Clinical Implications and Risk Stratification

Hormonal Dysfunction Risk

The presence of empty sella carries substantial risk for hypopituitarism, particularly when discovered due to clinical suspicion rather than incidentally. In primary empty sella, 40.5% of patients exhibit one or more pituitary axis deficiencies, though this drops to 29% in incidentally discovered cases 1.

Key predictors of hypopituitarism include:

  • Male sex (P = 0.02)
  • Clinical suspicion versus incidental finding (P <0.001)
  • Traumatic brain injury history (P = 0.003)
  • Total empty sella versus partial (higher risk)
  • Progression from partial to total empty sella (associated with hormonal deterioration, P = 0.006) 1

Specific Hormone Deficiencies

In clinically suspicious cases versus incidental findings:

  • Hypogonadism: 50.4% vs 8.5%
  • Hypothyroidism: 29.2% vs 2.8%
  • Growth hormone deficiency: 20.4% vs 12.5%
  • Hyperprolactinemia: 15.7% vs 2.9%
  • Hypocortisolism: 17.7% vs 13.5% (similar rates)
  • Diabetes insipidus: 1.7% vs 0.9% (similar rates) 1

Distinguishing Incidental from Pathologic Empty Sella

Patients with IIH-related empty sella are significantly younger (mean age 36.1 vs 54.3 years), more likely to report headaches (93.3% vs 32.6%) and visual complaints (66.2% vs 28.3%), and show greater scalp thickness (9.0 vs 6.4 mm) and neck soft-tissue thickness (19.5 vs 13.8 mm) 4.

Pediatric Considerations

In children, empty sella is more clinically significant than in adults and more frequently associated with endocrinopathies 2. The incidence ranges from 1.2% in children without endocrine symptoms to 68% in those with known endocrinopathy. Growth hormone deficiency, hypogonadotropism, and multiple pituitary hormone deficiencies are particularly common 2.

Associated Conditions

Empty sella shows strong clinical associations with:

  • Spontaneous CSF leaks and nasal meningoencephaloceles: 15 of 16 patients with spontaneous encephaloceles had empty or partially empty sellas, with mean CSF pressure of 28.3 cm H₂O (normal <15 cm) 6
  • Benign intracranial hypertension
  • Obesity (mean BMI 35.9 kg/m² in affected patients) 6

Common Pitfalls

Do not assume empty sella is always benign or incidental. While often asymptomatic, the condition warrants endocrine evaluation given the 29-40% risk of hormonal dysfunction even in incidental cases 1, 7. The discrepancy between high reported prevalence of pituitary insufficiency (52% in pooled analysis) and low prevalence in epidemiologic studies suggests many cases go unrecognized 7.

Pituitary volume does not correlate with function—even partial empty sella can cause significant hormonal deficits 1.

References

Research

Empty sella syndrome.

Pediatric endocrinology reviews : PER, 2012

Research

A Comprehensive Review of Empty Sella and Empty Sella Syndrome.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2024

Research

Factors determining the clinical significance of an "empty" sella turcica.

AJR. American journal of roentgenology, 2013

Research

The empty sella. A reappraisal of etiology and pathogenesis.

Acta neurologica Scandinavica. Supplementum, 1990

Related Questions

What is an empty sella?
What are the anesthesia considerations for a patient with empty sella syndrome?
Which blood tests should be ordered to evaluate empty sella syndrome?
What is the recommended evaluation and management for a patient with a mildly enlarged empty sella who is asymptomatic?
In a patient with chronic migraines and worsening headache whose brain CT reveals a partially empty sella, should this be considered an incidental finding or warrant further endocrine and neuro‑ophthalmologic evaluation?
How can I explain to a patient why taking two 5 mg extended‑release (XR) Adderall (mixed amphetamine salts) tablets is not equivalent to one 10 mg XR tablet when the 10 mg XR is unavailable?
What evaluation and management are indicated for a 75-year-old patient with a right total knee arthroplasty who cannot flex beyond 60 degrees and has persistent pain?
Can fluvoxamine be prescribed at 50 mg twice daily?
In a patient with heart failure, renal failure, atrial fibrillation with a ventricular rate of 160 bpm, severe hypertension (systolic ~200 mm Hg) and hypoxemia (SpO₂ ≈ 82 %), who has been treated with continuous positive airway pressure (CPAP) and nitroglycerin, when should rate‑control therapy be initiated?
What is the recommended dilution and dosage of pemetrexed (500 mg/m²) for intravenous infusion, including preparation, infusion volume, and renal dose adjustments?
I am taking levothyroxine 150 µg daily and atorvastatin 10 mg; my recent labs show suppressed thyroid‑stimulating hormone (TSH) at 0.07 uIU/mL, normal free triiodothyronine (free T3), elevated free thyroxine (free T4) at 1.80 ng/dL, and a lipid panel with calculated low‑density lipoprotein (LDL) 62 mg/dL, triglycerides 40 mg/dL, high‑density lipoprotein (HDL) 58 mg/dL, and cholesterol/HDL ratio 2.2. What adjustments should I make to my levothyroxine dose and lipid management?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.